Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa.

Autor: Janivara R; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Chen WC; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Cancer Registry, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa., Hazra U; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Baichoo S; University of Mauritius, Réduit, Mauritius., Agalliu I; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Kachambwa P; Centre for Proteomic and Genomic Research, Cape Town, South Africa.; Mediclinic Precise Southern Africa, Cape Town, South Africa., Simonti CN; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Brown LM; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Tambe SP; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Kim MS; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Harlemon M; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Jalloh M; Université Cheikh Anta Diop de Dakar, Dakar, Senegal.; Université Iba Der Thiam de Thiès, Thiès, Senegal., Muzondiwa D; Centre for Proteomic and Genomic Research, Cape Town, South Africa., Naidoo D; Centre for Proteomic and Genomic Research, Cape Town, South Africa., Ajayi OO; Centre for Proteomic and Genomic Research, Cape Town, South Africa., Snyper NY; 37 Military Hospital, Accra, Ghana., Niang L; Université Cheikh Anta Diop de Dakar, Dakar, Senegal., Diop H; Université Cheikh Anta Diop de Dakar, Dakar, Senegal., Ndoye M; Université Cheikh Anta Diop de Dakar, Dakar, Senegal., Mensah JE; Korle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana., Abrahams AOD; Korle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana., Biritwum R; Korle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana., Adjei AA; Department of Pathology, University of Ghana Medical School, Accra, Ghana., Adebiyi AO; College of Medicine, University of Ibadan, Ibadan, Nigeria., Shittu O; College of Medicine, University of Ibadan, Ibadan, Nigeria., Ogunbiyi O; College of Medicine, University of Ibadan, Ibadan, Nigeria., Adebayo S; College of Medicine, University of Ibadan, Ibadan, Nigeria., Nwegbu MM; College of Health Sciences, University of Abuja, University of Abuja Teaching Hospital and Cancer Science Centre, Abuja, Nigeria., Ajibola HO; College of Health Sciences, University of Abuja, University of Abuja Teaching Hospital and Cancer Science Centre, Abuja, Nigeria., Oluwole OP; College of Health Sciences, University of Abuja, University of Abuja Teaching Hospital and Cancer Science Centre, Abuja, Nigeria., Jamda MA; College of Health Sciences, University of Abuja, University of Abuja Teaching Hospital and Cancer Science Centre, Abuja, Nigeria., Pentz A; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Haiman CA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Spies PV; Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., van der Merwe A; Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Watya S; Uro Care, Kampala, Uganda., Lubwama A; Uro Care, Kampala, Uganda., Muchengeti M; National Cancer Registry, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa., Doherty S; Division of Urology, Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Smyth N; Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lounsbury D; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Fortier B; Dana-Farber Cancer Institute, Boston, MA, USA., Rohan TE; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Jacobson JS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York City, NY, USA., Neugut AI; Herbert Irving Comprehensive Cancer Center, Columbia University, New York City, NY, USA., Hsing AW; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Aisuodionoe-Shadrach OI; College of Health Sciences, University of Abuja, University of Abuja Teaching Hospital and Cancer Science Centre, Abuja, Nigeria., Joffe M; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Adusei B; 37 Military Hospital, Accra, Ghana., Gueye SM; Université Cheikh Anta Diop de Dakar, Dakar, Senegal., Fernandez PW; Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., McBride J; Centre for Proteomic and Genomic Research, Cape Town, South Africa., Andrews C; Dana-Farber Cancer Institute, Boston, MA, USA., Petersen LN; Centre for Proteomic and Genomic Research, Cape Town, South Africa.; Mediclinic Precise Southern Africa, Cape Town, South Africa., Lachance J; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA. joseph.lachance@biology.gatech.edu., Rebbeck TR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. timothy_rebbeck@dfci.harvard.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. timothy_rebbeck@dfci.harvard.edu.

Publikováno v: Nature genetics [Nat Genet] 2024 Oct; Vol. 56 (10), pp. 2093-2103. Date of Electronic Publication: 2024 Oct 02.

Continuous mechanical chest compression using the LUCAS-2 device as a bridge to emergency aortic valve surgery.

Autor: Tambe SP, Rasmussen VG, Modrau IS

Publikováno v: Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2012 Oct; Vol. 26 (5), pp. e50-2. Date of Electronic Publication: 2012 May 24.

Case 2--2008 rheumatic mitral stenosis associated with partial anomalous pulmonary venous return.

Autor: Koshy T; Department of Anaesthesiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala, India., Tambe SP, Sinha PK, Karmarkar V, Bhupali AN, Tempe DK, Koch CG

Publikováno v: Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2008 Apr; Vol. 22 (2), pp. 302-10.